- call +1-201-465-4211
- email sales@mrinsights.biz
Neuroprotection is defined as an involvement able to affect the etiology or the pathogenesis underlying neurodegenerative diseases.
Scope of the Report:
This report studies the Neuroprotection market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Neuroprotection market by product type and applications/end industries.
The global Neuroprotection market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Neuroprotection.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
F. Hoffmann-La Roche
Eli Lilly and Company
Daiichi Sankyo Company
Allergan
Novartis
AstraZeneca
Dr. Reddy's Laboratories
Astrocyte Pharmaceuticals
Teva Pharmaceutical Industries
Biogen
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Free Anti-Inflammatory Agents
Radical Trapping Agents (Antioxidants)
Apoptosis Inhibitors
Glutamate Antagonists (Anti-Excitotoxic Agents)
Neurotrophic Factors (NTFs)
Stimulants
Metal Ion Chelators
Other Products
Market Segment by Applications, can be divided into
Prevention
Treatment
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Neuroprotection Market Overview
1.1 Product Overview and Scope of Neuroprotection
1.2 Classification of Neuroprotection by Types
1.2.1 Global Neuroprotection Revenue Comparison by Types (2017-2023)
1.2.2 Global Neuroprotection Revenue Market Share by Types in 2017
1.2.3 Free Anti-Inflammatory Agents
1.2.4 Radical Trapping Agents (Antioxidants)
1.2.5 Apoptosis Inhibitors
1.2.6 Glutamate Antagonists (Anti-Excitotoxic Agents)
1.2.7 Neurotrophic Factors (NTFs)
1.2.8 Stimulants
1.2.9 Metal Ion Chelators
1.2.10 Other Products
1.3 Global Neuroprotection Market by Application
1.3.1 Global Neuroprotection Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Prevention
1.3.3 Treatment
1.4 Global Neuroprotection Market by Regions
1.4.1 Global Neuroprotection Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Neuroprotection Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Neuroprotection Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Neuroprotection Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Neuroprotection Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Neuroprotection Status and Prospect (2013-2023)
1.5 Global Market Size of Neuroprotection (2013-2023)
2 Manufacturers Profiles
2.1 F. Hoffmann-La Roche
2.1.1 Business Overview
2.1.2 Neuroprotection Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 F. Hoffmann-La Roche Neuroprotection Revenue, Gross Margin and Market Share (2016-2017)
2.2 Eli Lilly and Company
2.2.1 Business Overview
2.2.2 Neuroprotection Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Eli Lilly and Company Neuroprotection Revenue, Gross Margin and Market Share (2016-2017)
2.3 Daiichi Sankyo Company
2.3.1 Business Overview
2.3.2 Neuroprotection Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Daiichi Sankyo Company Neuroprotection Revenue, Gross Margin and Market Share (2016-2017)
2.4 Allergan
2.4.1 Business Overview
2.4.2 Neuroprotection Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Allergan Neuroprotection Revenue, Gross Margin and Market Share (2016-2017)
2.5 Novartis
2.5.1 Business Overview
2.5.2 Neuroprotection Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Novartis Neuroprotection Revenue, Gross Margin and Market Share (2016-2017)
2.6 AstraZeneca
2.6.1 Business Overview
2.6.2 Neuroprotection Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 AstraZeneca Neuroprotection Revenue, Gross Margin and Market Share (2016-2017)
2.7 Dr. Reddy's Laboratories
2.7.1 Business Overview
2.7.2 Neuroprotection Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Dr. Reddy's Laboratories Neuroprotection Revenue, Gross Margin and Market Share (2016-2017)
2.8 Astrocyte Pharmaceuticals
2.8.1 Business Overview
2.8.2 Neuroprotection Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Astrocyte Pharmaceuticals Neuroprotection Revenue, Gross Margin and Market Share (2016-2017)
2.9 Teva Pharmaceutical Industries
2.9.1 Business Overview
2.9.2 Neuroprotection Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Teva Pharmaceutical Industries Neuroprotection Revenue, Gross Margin and Market Share (2016-2017)
2.10 Biogen
2.10.1 Business Overview
2.10.2 Neuroprotection Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Biogen Neuroprotection Revenue, Gross Margin and Market Share (2016-2017)
3 Global Neuroprotection Market Competition, by Players
3.1 Global Neuroprotection Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Neuroprotection Players Market Share
3.2.2 Top 10 Neuroprotection Players Market Share
3.3 Market Competition Trend
4 Global Neuroprotection Market Size by Regions
4.1 Global Neuroprotection Revenue and Market Share by Regions
4.2 North America Neuroprotection Revenue and Growth Rate (2013-2018)
4.3 Europe Neuroprotection Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Neuroprotection Revenue and Growth Rate (2013-2018)
4.5 South America Neuroprotection Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Neuroprotection Revenue and Growth Rate (2013-2018)
5 North America Neuroprotection Revenue by Countries
5.1 North America Neuroprotection Revenue by Countries (2013-2018)
5.2 USA Neuroprotection Revenue and Growth Rate (2013-2018)
5.3 Canada Neuroprotection Revenue and Growth Rate (2013-2018)
5.4 Mexico Neuroprotection Revenue and Growth Rate (2013-2018)
6 Europe Neuroprotection Revenue by Countries
6.1 Europe Neuroprotection Revenue by Countries (2013-2018)
6.2 Germany Neuroprotection Revenue and Growth Rate (2013-2018)
6.3 UK Neuroprotection Revenue and Growth Rate (2013-2018)
6.4 France Neuroprotection Revenue and Growth Rate (2013-2018)
6.5 Russia Neuroprotection Revenue and Growth Rate (2013-2018)
6.6 Italy Neuroprotection Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Neuroprotection Revenue by Countries
7.1 Asia-Pacific Neuroprotection Revenue by Countries (2013-2018)
7.2 China Neuroprotection Revenue and Growth Rate (2013-2018)
7.3 Japan Neuroprotection Revenue and Growth Rate (2013-2018)
7.4 Korea Neuroprotection Revenue and Growth Rate (2013-2018)
7.5 India Neuroprotection Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Neuroprotection Revenue and Growth Rate (2013-2018)
8 South America Neuroprotection Revenue by Countries
8.1 South America Neuroprotection Revenue by Countries (2013-2018)
8.2 Brazil Neuroprotection Revenue and Growth Rate (2013-2018)
8.3 Argentina Neuroprotection Revenue and Growth Rate (2013-2018)
8.4 Colombia Neuroprotection Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Neuroprotection by Countries
9.1 Middle East and Africa Neuroprotection Revenue by Countries (2013-2018)
9.2 Saudi Arabia Neuroprotection Revenue and Growth Rate (2013-2018)
9.3 UAE Neuroprotection Revenue and Growth Rate (2013-2018)
9.4 Egypt Neuroprotection Revenue and Growth Rate (2013-2018)
9.5 Nigeria Neuroprotection Revenue and Growth Rate (2013-2018)
9.6 South Africa Neuroprotection Revenue and Growth Rate (2013-2018)
10 Global Neuroprotection Market Segment by Type
10.1 Global Neuroprotection Revenue and Market Share by Type (2013-2018)
10.2 Global Neuroprotection Market Forecast by Type (2018-2023)
10.3 Free Anti-Inflammatory Agents Revenue Growth Rate (2013-2023)
10.4 Radical Trapping Agents (Antioxidants) Revenue Growth Rate (2013-2023)
10.5 Apoptosis Inhibitors Revenue Growth Rate (2013-2023)
10.6 Glutamate Antagonists (Anti-Excitotoxic Agents) Revenue Growth Rate (2013-2023)
10.7 Neurotrophic Factors (NTFs) Revenue Growth Rate (2013-2023)
10.8 Stimulants Revenue Growth Rate (2013-2023)
10.9 Metal Ion Chelators Revenue Growth Rate (2013-2023)
10.10 Other Products Revenue Growth Rate (2013-2023)
11 Global Neuroprotection Market Segment by Application
11.1 Global Neuroprotection Revenue Market Share by Application (2013-2018)
11.2 Neuroprotection Market Forecast by Application (2018-2023)
11.3 Prevention Revenue Growth (2013-2018)
11.4 Treatment Revenue Growth (2013-2018)
12 Global Neuroprotection Market Size Forecast (2018-2023)
12.1 Global Neuroprotection Market Size Forecast (2018-2023)
12.2 Global Neuroprotection Market Forecast by Regions (2018-2023)
12.3 North America Neuroprotection Revenue Market Forecast (2018-2023)
12.4 Europe Neuroprotection Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Neuroprotection Revenue Market Forecast (2018-2023)
12.6 South America Neuroprotection Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Neuroprotection Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Neuroprotection Picture
Table Product Specifications of Neuroprotection
Table Global Neuroprotection and Revenue (Million USD) Market Split by Product Type
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
